| ALT | alanine aminotransferase (glutamic pyruvic transaminase, GPT) |
| ALP | alkaline phosphatase |
| AST | aspartate aminotransferase (glutamic oxalic transaminase, GOT) |
| CCK | Caspase-cleaved cytokeratin (8 and 18) M-30 and M-65 |
| DAMPs | danger-associated molecular patterns |
| EBV | Epstein–Barr virus |
| EGF | endothelial growth factor |
| ELISA | enzyme-linked immunosorbent assay; |
| FasL/TNFSF6 | factor-related apoptosis ligand |
| Fas | ligand, a member of tumor necrosis factor super-family |
| FDA | Food and Drug Administration |
| GGT | γ-glutamyl transferase |
| HBV | hepatitis virus B |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis virus C |
| HCV-RNA | hepatitis C virus ribonucleic acid |
| HHV6 | human herpes virus 6 |
| IFN | interferon |
| IL | interleukin |
| INR | international normalized ratio |
| IRF | interferon regulatory factor |
| ISGs | IFN-stimulated genes |
| ISRE | IFN-stimulated response element |
| IU/L | international units/liter |
| Jak | Janus kinase |
| mean ± st. d | mean ± standard deviation |
| MIP | macrophage inflammatory protein-1 (CCR5 ligand) |
| MMP | matrix metalloprotease |
| NFκB | nuclear factor-κB |
| NLRP | NOD-like receptor pyrin domain |
| PAI -1 | plasminogen activator inhibitor 1 |
| PAMPs | pathogen-associated molecular patterns |
| pro-CASP-1 | procaspase 1 |
| PICP | C-terminal procollagen I peptide |
| PIIINP | amino-terminal propeptide of procollagen type III |
| PRRs | pattern recognition receptors |
| PYCARD | apoptosis-associated speck-like protein containing a CARD ASC |
| RANTES (CCL5) | regulated upon activation normal T cell expressed and secreted |
| RNA | ribonucleic acid |
| TGF | β-transforming growth factor beta |
| TIMP | tissue inhibitor of matrix metalloproteinase |
| TNF-α | tumor necrosis factor alpha |
| TLR | Toll-like receptors |
| VEGF | vascular endothelial growth factor |